ArticleInternational journal of cancer2018

Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide.

Jelena Belic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.